Medication info

1. Dotarem Injection 2. Dotarem Prefilled Syringe

Prescription medicationSolutionInjection
Ingredient · strength
DOTA›20.246g / 100mLGadolinium Oxide›9.062g / 100mLMeglumine›9.76g / 100mL
Manufacturer / importer
Guertbet Korea Ltd.
Appearance
Dotarem Injection: A colorless, slightly viscous liquid in a colorless vial, Dotarem Prefilled Syringe: A colorless glass or plastic tube (part of the prefilled syringe system) with both ends sealed.
Packaging
Dotarem Injection - 5 milliliters/vial [X manufacturer packaging unit], Dotarem Injection - 10 milliliters/vial [X manufacturer packaging unit], Dotarem Injection - 15 milliliters/vial [X manufacturer packaging unit], Dotarem Injection - 20 milliliters/vial [X manufacturer packaging unit], Dotarem Prefilled Syringe - 10 milliliters/prefilled syringe [X manufacturer packaging unit], Dotarem Prefilled Syringe - 15 milliliters/prefilled syringe [X manufacturer packaging unit], Dotarem P
Approval status
Active

MFDS item code 199806758 · Approved 1998.12.17 · Insurance code 654900011,654900021,654900031,654900041,

Summary

Main use
Improvement of contrast enhancement on MRI of the body (including MR angiography), cranial nervous system·spine
Who receives it
Adults · Children
Adult administration
Adults and children (0 to 18 years) are administered 0.1 mmol/kg (0.2 mL/kg) of this drug intravenously. Adults only - In exceptional cases, such as diagnosis of leptomeningeal tumors and identification of solitary metastatic lesions, an additional 0.2 mmol/kg (0.4 mL/kg) may be administered intravenously. - During angiography, an additional 0.1 mmol/kg (0.2 mL/kg) may be administered according to the imaging results.
Child administration
0 to 18 years: 0.1 mmol/kg (0.2 mL/kg)

Ingredients

Importer
Guertbet Korea Ltd.

Efficacy & effects

Improvement of contrast enhancement on MRI of the body (including MR angiography), cranial nervous system·spine

View approved original text

This medication helps to clearly identify lesions during MRI imaging of the central nervous system and spine. It is also used in MRI imaging of the body and angiography to assist in diagnosing the condition and abnormalities of blood vessels. Therefore, it is used to accurately assess abnormal findings in the brain, spine, and internal blood vessels.

How it is given

Adult administration

Adults and children (0 to 18 years) are administered 0.1 mmol/kg (0.2 mL/kg) of this drug intravenously. Adults only - In exceptional cases, such as diagnosis of leptomeningeal tumors and identification of solitary metastatic lesions, an additional 0.2 mmol/kg (0.4 mL/kg) may be administered intravenously. - During angiography, an additional 0.1 mmol/kg (0.2 mL/kg) may be administered according to the imaging results.

Child administration

0 to 18 years: 0.1 mmol/kg (0.2 mL/kg)

Precautions

This medicine has the risk of causing a serious side effect called nephrogenic systemic fibrosis if administered to patients with severely impaired kidney function or those with combined liver and kidney dysfunction. It is advisable to avoid using this medication in such patients, and if necessary, it should be used with caution. This drug should not be injected into the spinal canal, as it may lead to serious adverse reactions. Repeated administration may result in abnormal signals in specific areas of the brain, although the clinical significance of this is not yet clear. It should not be given to patients with allergies to this drug or its components or those with metallic foreign bodies contraindicated for MRI. Particularly frail patients, those with asthma, severe liver or kidney disorders, allergic individuals, those with a history of convulsive disorders, cardiovascular diseases, the elderly, and children should use this medication with caution. Common side effects include injection site reactions, nausea, headache, and rare cases of severe allergic reactions, convulsions, and shock; patients must be monitored for at least 30 minutes after administration. The risk of side effects may increase with repeated dosing or high doses, so strict dosage limits must be adhered to, and kidney function should be assessed to ensure patient safety. In preparation for emergencies, appropriate medications and emergency equipment should be available, and administration should be performed by experienced professionals. Pregnant or breastfeeding women should carefully consider the potential effects on the fetus or infant before using this medication, and breastfeeding should preferably be paused for a period after administration. The safety and efficacy for children have not been sufficiently demonstrated, so if necessary, the minimum dose should be used with adequate intervals between doses. The elderly may have decreased kidney function, so kidney function should be confirmed before administration. In cases of overdose, fluids and electrolytes should be replenished, and kidney function monitored, with blood dialysis considered to remove this drug if needed. This medication must be administered only intravenously, and care should be taken to avoid local reactions in case of leakage at the injection site. Any leftover medication should be discarded, and prefilled syringes are for single use only and should not be reused.

Side effects

  • Burning sensation
  • itching
  • red or dark spots
  • swelling
  • hardening
  • stiffness
  • yellow spots on the sclera of the eye
  • joint stiffness
  • movement disorders of the arms
  • hands
Show 90 more
  • legs
  • and feet
  • deep pain in the hip bone or ribs
  • myasthenia
  • shock
  • fainting
  • loss of consciousness
  • shortness of breath
  • respiratory arrest
  • cardiac arrest
  • shortness of breath
  • angioedema
  • facial edema
  • convulsions
  • injection site reactions
  • nausea
  • headache
  • cold sensation
  • hypotension
  • drowsiness
  • dizziness
  • warmth sensation
  • heat sensation
  • rash
  • lethargy
  • taste disorder
  • hypertension
  • vomiting
  • itching
  • hypersensitivity
  • anxiety
  • restlessness
  • sensory abnormalities
  • total fainting
  • coma
  • syncope
  • olfactory disorders
  • tremors
  • eyelid edema
  • conjunctivitis
  • eye congestion
  • blurred vision
  • increased nasal discharge
  • palpitations
  • cardiac arrest
  • bradycardia
  • tachycardia
  • arrhythmia
  • hypotension
  • hypertension
  • vasodilation
  • pallor
  • flushing
  • warmth sensation
  • sneezing
  • throat tightness
  • respiratory arrest
  • pulmonary edema
  • bronchospasm
  • laryngeal spasm
  • pharyngeal edema
  • shortness of breath
  • congestion
  • cough
  • dry mouth
  • foreign body sensation in the throat
  • abdominal pain
  • diarrhea
  • excessive salivation
  • urticaria
  • hyperhidrosis
  • erythema
  • eczema
  • angioedema
  • muscle cramps
  • muscle weakness
  • low back pain
  • arthralgia
  • warmth sensation
  • cold sensation
  • lethargy
  • chest pain
  • chills
  • fatigue
  • chest discomfort
  • facial edema
  • fever
  • injection site necrosis
  • superficial thrombophlebitis
  • decreased oxygen saturation

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container that prevents air entry and kept at room temperature between 1°C and 30°C for optimal effect.

Appearance and packaging

Appearance

Dotarem Injection: A colorless, slightly viscous liquid in a colorless vial, Dotarem Prefilled Syringe: A colorless glass or plastic tube (part of the prefilled syringe system) with both ends sealed.

Package unit

Dotarem Injection - 5 milliliters/vial [X manufacturer packaging unit], Dotarem Injection - 10 milliliters/vial [X manufacturer packaging unit], Dotarem Injection - 15 milliliters/vial [X manufacturer packaging unit], Dotarem Injection - 20 milliliters/vial [X manufacturer packaging unit], Dotarem Prefilled Syringe - 10 milliliters/prefilled syringe [X manufacturer packaging unit], Dotarem Prefilled Syringe - 15 milliliters/prefilled syringe [X manufacturer packaging unit], Dotarem P

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.